Answers are grounded in this paper and cite their sources.
An integrated cell-penetrating peptide-assembly-based nanomaterial is engineered as a dual-mode strategy for enhancing nanotherapeutic tumor targeting and penetration through recognition and depletion of cancer-associated fibroblasts. The dual-mode strategy is composed of cancer-associated fibroblast-specific antibody targeting for overcoming tissue barrier and cell-penetration peptide-mediated enhanced cellular uptake.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: